Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis

Fertility and Sterility

Volumn 78, Issue 4, 2002, Pages 733-739

  Harada, Tatsuya ^a,b   Kubota, Toshiro ^a   Aso, Takeshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Department of Comprehensive Reproductive Medicine ^*  (Japan)

Author keywords

CA125; CA19 9; Diagnosis; Endometriosis; Revised American Fertility Society Classification; Severity

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN;

ADULT; BLOOD LEVEL; BLOOD SAMPLING; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LAPAROSCOPY; MAJOR CLINICAL STUDY; OVARIECTOMY; OVARY CYST; PRIORITY JOURNAL; STAINING; TISSUE SLICE;

ADULT; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CYSTECTOMY; ENDOMETRIOSIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; MIDDLE AGED; OVARIAN CYSTS; OVARIECTOMY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0036789588     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03328-9     Document Type: Conference Paper

References (22)

1. Koprowski H., Steplewski Z., Mitchell K., Herlyn M., Herlyn D., Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 5:1979;957-972.
2. Ohshio G., Yamaki K., Imamura T., Suwa H., Chang C.Y., Imamura M., et al. Distribution of the carbohydrate antigens, DU-PAN-2 and CA19-9, in tumors of the lung. Tumori. 81:1995;67-73.
3. Del Villano B.C., Brennam S., Brock P., Bucher C., Liu V., Zurawski V.R. Jr, et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA19-9. Clin Chem. 29:1983;549-552.
4. Ye C., Ito K., Kamatsu Y., Takagi H. Extremely high levels of CA19-9 and CA125 antigen in benign mucinous ovarian cystadenoma. Gynecol Oncol. 52:1994;267-271.
5. Imai A., Horibe S., Takagi A., Takagi H., Tamaya T. Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis. Eur J Obstet Gynecol Biol. 78:1998;79-81.
6. Takemori M., Sugimura K. Ovarian chocolate cyst with markedly elevated serum CA19-9 level a case report . Eur J Obstet Gynecol Biol. 42:1991;241-244.
7. Matlliotakis I., Panidis D., Vlassis G., Neonaki M., Goumenou A., Koumantakis E. Unexpected increase of the CA19-9 tumour marker in patients with endometriosis. Eur J Gynaecol Oncol. 19:1998;498-500.
8. Hornstein M.D., Harlow B.L., Thomas P.P., Check J.H. Use of a new CA125 assay in the diagnosis of endometriosis. Hum Reprod. 10:1995;932-934.
9. O'Shaughnessy A., Check J.H., Nowroozi K., Lurie D. CA125 levels measured in different phases of the menstrual cycle in screening for endometriosis. Obstet Gynecol. 81:1993;99-103.
10. Hornstein M.D., Thomas P.P., Gleason R.E., Barbieri R.L. Menstrual cyclicity of CA125 in patients with endometriosis. Fertil Steril. 58:1992;279-283.
11. Koninckx P.R., Riittinen L., Seppala M., Cornillie F.J. CA125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with infiltrating pelvic endometriosis. Fertil Steril. 57:1992;523-530.
12. Mol B.W.J., Bayram N., Lijmer J.G., Wiegerinck M.A.H.M., Bongers M.Y., Bossuyt P.M.M., et al. The performance of CA-125 measurement in the detection of endometriosis a meta-analysis . Fertil Steril. 70:1998;1101-1108.
13. Chen F.P., Soong Y.K., Lee N., Lo S.K. The use of serum CA-125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand. 77:1998;665-670.
14. Jacobs I., Bast R.C. Jr. The CA125 tumour-associated antigen a review of the literature . Hum Reprod. 4:1989;1-12.
15. Pittaway D.E., Fayez J.A. Serum CA-125 antigen levels increase during menses. Am J Obstet Gynecol. 156:1987;75-76.
16. Kaku T., Kamura Y., Hirakawa T., Sakai K., Amada S., Nakano H., et al. Endometrial carcinoma associated with hyperplasia. Immunohistochemical study of angiogenesis and p53 expression. Gynecol Oncol. 72:1999;51-55.
17. Magnani J.L., Nilsson B., Brockhaus M., Zopf D., Steplewski Z., Ginsburg V., et al. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem. 257:1982;14365-14369.
18. x is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem. 266:1991;14869-14872.
19. x. Science. 250:1990;1130-1132.
20. Takada T., Ohmori K., Yoneda T., Tsuyuoka K., Hasegawa A., Kannagi R., et al. Contribution of carbohydrate antigen sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53:1993;354-361.
21. Yamada N., Chung Y.S., Takatsuka S., Atimoto Y., Sawada T., Sowa M., et al. Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line. Br J Cancer. 76:1997;582-587.
22. Espaulella J., Armengol J., Bella F., Lain J.M., Calaf J. Pulmonary endometriosis conservative treatment with GnRH agonists. Obstet Gynecol. 78:1991;535-537.